Company American BriVision (Holding) Corporation OTC Markets
Equities
ABVC
US0247332069
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
New Drugs and Medical Devices
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -84.28% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -84.28% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 23-06-22 | |
Leeds Chow
DFI | Director of Finance/CFO | 35 | 21-02-28 |
Eugene Jiang
CHM | Chairman | 38 | 15-06-30 |
Chief Tech/Sci/R&D Officer | 70 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yue Min Chung
BRD | Director/Board Member | 59 | 22-07-09 |
Shu Ling Chiang
BRD | Director/Board Member | 68 | - |
Eugene Jiang
CHM | Chairman | 38 | 15-06-30 |
Tsang Ming Jiang
BRD | Director/Board Member | 63 | 17-11-22 |
Norimi Sakamoto
BRD | Director/Board Member | 53 | 17-11-22 |
Yen-Hsin Chou
BRD | Director/Board Member | 43 | 17-11-22 |
Chief Tech/Sci/R&D Officer | 70 | - | |
Chang-Jen Jiang
BRD | Director/Board Member | 68 | - |
Yoshinobu Odaira
BRD | Director/Board Member | 76 | - |
Hsin-Hui Miao
BRD | Director/Board Member | 57 | 22-06-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,878,376 | 8,003,762 ( 73.57 %) | 26,553 ( 0.2441 %) | 73.57 % |
Company contact information
![address American BriVision (Holding) Corporation(ABVC)](https://cdn.zonebourse.com/static/address/111313628.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |